OraSure Technologies Inc., the Bethlehem-based company that earlier this year developed a test for Ebola, will sell $1.5 million of its new product to the Centers for Disease Control and Prevention. The OraQuick Ebola Rapid Antigen Test uses the same technology OraSure deployed for creating its rapid HIV and HCV tests. Read more: http://bit.ly/1KQg2Bl
Client & Alumni News
OraSure receives $1.5M Ebola Test Order from CDC
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.